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ABSTRACT 
A novel series of medium size (S)-3-alkyl-3,4,6,7-tetrahydro-1H-benzo[e][1,4]diazonine-2,5-dione (6a-f) ana-
logues were synthesized from (E)-3-(2-nitrophenyl)acrylicacid (2) reacting with various amino acid esters using 
Di-isopropyl Carbodiimide as a coupling agent. The final cyclization is carried out by using reagent 1-Ethyl-3(3-
dimethylaminopropyl) Carbodiimide Hydrochloride. The synthesized compounds have been supported by Mass, 
1H-NMR and 13C-NMR. Further antibacterial studies were conducted, where some molecules are noticed with 
potent activity, especially molecule 6d shown highest activity which was also supported by molecular docking 
studies. All final molecules were docked with enzyme peptide deformylase to determine the probable binding 
conformation. 
 
Keywords: medium size ring, synthesis, coupling reaction, lactam, bacillus subtilis, anti-bacterial, docking 
 
 
 
INTRODUCTION 
Over the years, antibacterial agents are 
playing a vital role to treat infectious diseases 
(Woon and Fisher, 2016). Apart from the in-
creasing new diseases, emerging resistance in 
bacteria against available antibacterial agents 
is a world-wide problem (Lin et al., 2015; 
Brickner et al., 1996; Neu, 1985). Even 
though the design, development and expan-
sion of a number of new antibacterial agents 
against such bacteria, their clinical value is in-
adequate to treat an exceeding group of life 
threatening systemic infections because of 
their comparatively high risk of toxicity 
(Sanders and Sanders, 1979), emergence of 
drug resistant strains (Ventola, 2015; Neu, 
1992), pharmacokinetic differences, and in-
sufficiencies in their activity (Bush, 2004; 
Levison and Levison, 2009). Our research 
community is trying to synthesize molecules 
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which are having better pharmacokinetic 
properties and are sufficient in their activity. 
Literature results show, the 9-membered 
medium size ring molecules and macrocycles 
are bioactive and have promising therapeutic 
potential value (Driggers et al., 2008). Espe-
cially macrocycles provide pre-organized ring 
structure to molecules and are ideal for bind-
ing protein surface (Reayi and Arya, 2005; Yu 
and Sun, 2013; Marsault and Peterson, 2011; 
Kopp et al., 2012). Meseguer and co-workers 
(1999, 2000), synthesized libraries of indolac-
tam analogs, where the 9-membered ring 
structure is present in a natural product Indo-
lactam V (F1.1), the core structure of tumor-
protecting teleocidins. Marcantoni and co-
workers (2000) synthesized a 9-membered 
medium size macrocyclic ring component of 
Griseoviridin (F1.2) which is a broad spec-
trum antibiotic with in vitro inhibitory activity 
toward various pathogenic fungi and bacteria 
(Figure 1).  
 
 
Figure 1: 9-membered ring containing molecules 
in nature 
 
 
A series of medium size ring [(S)-3-alkyl-
3,4,6,7-tetrahydro-1H-benzo[e][1,4]diazoni-
ne-2,5-dione] molecules (6a-f) was synthe-
sized on benzene ring and screened for anti-
bacterial activity. The key reactions that are 
involved for constructing this (medium size) 
ring are reduction of nitro group and amino 
ester coupling reactions (Figure 2). 
 
NH NH
O
O R
entry R=
1 sec-Bu
2 Bn
3 i-Pr
4 i-Bu6
5 Me
6 H
Figure 2: Retrosynthesis of 9-membered ring 
molecule 
 
(S)-3-alkyl-3,4,6,7-tetrahydro-1H-benzo 
[e] [1,4]diazonine-2,5-dione analogues (6a-f) 
are synthesized from intermediate (E)-3-(2-
nitrophenyl)acrylic acid (2) reacting with var-
ious amino acid ester. The intermediate (E)-3-
(2-nitrophenyl)acrylic acid (2) is in-turn syn-
thesized from o-Nitrobenzaldehyde. The final 
step cyclization is carried out using reagent 1-
ethyl-3(3-dimethylaminopropyl) carbodi-
imide hydrochloride and acetonitrile as sol-
vent. Further, the synthesized compounds 
were screened for antibacterial activity.  
 
MATERIALS AND METHODS 
Chemistry 
All solvents and reagents were used, as re-
ceived from the suppliers and some of them 
were distilled before use. All the reactions 
were monitored by thin layer chromatography 
(TLC) on pre-coated silica gel 60F254 
(Merck, 1.05554) and the spots were visual-
ized with UV light at 254 nm or alternatively 
by staining with ninhydrine or potassium per-
manganate or ceric ammonium molybdate. 
Flash column chromatography was per-
formed using silica gel (Merck, 60A, 230-400 
Mesh). All reactions were performed in oven 
dried glassware. Dimethylformamide, di-
chloromethane, methanol and tetrahydrofuran 
were dried immediately prior to use according 
to standard procedures: Dimethylformamide, 
dichloromethane was distilled under N2 from 
CaH2, methanol was distilled under N2 over 
Mg and tetrahydrofuran was distilled under 
N2 over Na. All solvents were removed by 
evaporation under reduced pressure. 1H-NMR 
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and 13C-NMR spectra were recorded on Var-
ian 400 MHz CDCl3 using TMS as internal 
standard. Electron impact (EI) and chemical 
ionization mass spectra were recorded on an 
Agilent-6430 mass spectrometer instrument. 
General procedure for synthesis of (E)-ethyl 
3-(2-nitrophenyl)acrylate (1) 
To a solution of sodium hydride in dry tet-
rahydrofuran and triethyl phosphonoacetate 
was added at 0 °C, and stirred under nitrogen 
atmosphere for 30 min. A solution of 2-nitro-
benzaldehyde in tetrahydrofuran was then 
added drop wise to the reaction mixture and 
allowed to stir for 4 h at 0 °C. After comple-
tion of the reaction (monitored through TLC), 
the reaction mixture was quenched by adding 
saturated ammonium chloride solution and it 
was extracted with ethyl acetate. The col-
lected organic layers were washed with brine 
solution, and then dried over anhydrous so-
dium sulphate. The solution was filtered and 
concentrated, which was then purified by col-
umn chromatography to give a yellow liquid 
compound. 
General procedure for synthesis of (E)-3-(2-
nitrophenyl)acrylic acid (2) 
To the solution of ester in methanol and 
water, lithium hydroxide monohydrate was 
added. The reaction mixture was stirred at 
50 °C for 12 h. After completion of reaction 
(monitored through TLC), methanol was re-
moved under reduced pressure. The obtained 
aqueous solution was added with HCl till the 
pH is in between 5-6 and then extracted with 
ethyl acetate. The combined organic phase 
were dried over sodium sulfate, filtered and 
concentrated to obtained light yellow colour 
solid compound. 
General procedure for synthesis of  
compounds (3a-f) 
To a suspension of compound (2) in dry 
dimethylformamide, amino ester, diisopropyl 
carbodiimide, 1-hydroxy-1H-benzotriazole 
and N, N-diisopropylethylamine were added 
at 0 °C and allowed to stirred for 12 h under 
nitrogen atmosphere. After completion of the 
reaction (which was monitored through TLC), 
solution was quenched with sodium bicar-
bonate solution and further extracted with 
ethyl acetate. The obtained organic layer was 
washed with brine solution, and then dried 
over anhydrous sodium sulphate. The solution 
was filtered and concentrated to leave a crude 
oil. The obtained liquid was purified by col-
umn chromatography to give the pure com-
pound. 
General procedure for synthesis of  
compounds (4a-f) 
To a suspension of compound (3a-f) in ab-
solute ethanol, 10 % Pd/C was added and 
stirred the reaction mixture for 12 h under hy-
drogen atmosphere at room temperature. Af-
ter completion of the reaction (monitored 
through TLC), the reaction mixture was 
passed through celite and concentrated. The 
crude compound was subjected to column 
chromatography to give white colour oily 
compound. 
General procedure for synthesis of  
compounds (5a-f) 
To the suspension of ester (4a-f) in Tetra-
hydrofuran and water, Lithium hydroxide 
Monohydrate was added. For 12 h the reac-
tion mixture was stirred at room temperature. 
The reaction was monitored through TLC. 
Later after completion of reaction, the solu-
tion was filtered and extracted with ethyl ace-
tate. The obtained liquid was dried over so-
dium sulfate, filtered and concentrated. 
General procedure for synthesis of  
compounds (6a-f) 
To the suspension of acid (5a-f) in ace-
tonitrile, 1-ethyl-3(3-dimethylaminopropyl) 
carbodiimide hydrochloride were added at 
room temperature and allow to stir under ni-
trogen atmosphere for 12 h. After finishing of 
reaction (which was monitored through TLC), 
the solution was quenched with sodium bicar-
bonate solution. It was then concentrated and 
extracted with ethyl acetate. The collected or-
ganic layer was washed with brine solution 
and it was dried over anhydrous sodium sul-
phate. The solution was then filtered and con-
centrated to give a crude oil, later purified by 
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column chromatography to give pure com-
pound. 
(S)-3-isobutyl-3,4,6,7-tetrahydro-1H-
benzo[e][1,4]diazonine-2,5-dione (6a) 
Molecular Formula : C15H20N2O2;Rf: 0.2 
at 0.2: 9.8 ethyl acetate/DCM; Yield : 26 %; 
1H-NMR (400 MHz, CDCl3) δppm : 8.24 (d, 
J = 8.01 Hz, 1H), 7.38-7.09 (m, 4H), 4.20 (m, 
1H), 3.02-2.95 (m, 2H), 2.88 (m, 2H), 2.05 
(m, 1H), 1.82 (m, 1H), 1.54 (m, 1H), 1.02 (m, 
J = 17.83, 6.64 Hz, 6H); 13C-NMR (100 
MHz, CDCl3) δppm : 180.6, 160.6, 133.7, 
128.3, 127.8, 126.2, 125.2, 117.5, 67.2, 40.7, 
29.7, 25.9, 25.2, 23.2, 21.7; LRMS : (ES+) 
m/z = 242.8 (Fragmented ion). 
(S)-3-benzyl-3,4,6,7-tetrahydro-1H-
benzo[e][1,4]diazonine-2,5-dione (6b) 
Molecular Formula : C18H18N2O2; Rf: 0.2 
at 3 : 7 of ethyl acetate/hexanes; Yield : 10 %; 
1H-NMR (400 MHz,CDCl3) δppm : 8.16 (d, J 
= 8.15 Hz, 1H),7.32-7.07 (m, 9H), 4.50-4.44 
(s, 1H),3.36 (m, 1H), 3.13 (m, 1H), 2.77 
(m,4H); 13C-NMR (100 MHz,CDCl3) δppm : 
179.2, 161.2, 136.0, 133.4, 129.5, 128.2, 
128.1, 127.7, 126.7, 126.2, 125.3, 117.5, 69.2, 
37.2, 29.7, 25.7, 25.7; LRMS : (ES+) m/z = 
276.7 (Fragmented ion). 
(S)-3-isopropyl-3,4,6,7-tetrahydro-1H-
benzo[e][1,4]diazonine-2,5-dione (6c) 
Molecular Formula : C14H18N2O2; Rf: 0.3 
at 3 : 7 ethyl acetate/hexanes; Yield : 46 %; 
1H-NMR (400 MHz, CDCl3) δppm : 8.25 (d, 
J = 8.13 Hz, 1H), 7.37-7.28 (m, 2H), 7.24 (d, 
J = 7.31 Hz, 1H), 7.16 (t, J = 7.46 Hz, 1H), 
4.10 (m, 1H) , 2.98 (m, J = 7.47 Hz, 2H), 
2.95-2.87 (m, 2H), 2.45-2.37 (m, 1H), 0.90 
(m, 6H); 13C-NMR (100 MHz, CDCl3) δppm 
: 179.5,161.2, 133.7, 128.3, 127.8, 126.2, 
125.2, 117.5, 73.6, 29.7, 26.1, 19.3, 16.8, 
14.1; LRMS : (ES+) m/z = 228.7 (Fragmented 
ion). 
(S)-3-sec-butyl-3,4,6,7-tetrahydro-1H-
benzo[e][1,4]diazonine-2,5-dione (6d) 
Molecular Formula : C15H20N2O2; Rf : 0.5 
at 3 : 7 ethyl acetate/hexanes; Yield : 
10 %;1H-NMR (400 MHz, CDCl3) δppm : 
8.26 (m, 1H), 7.29 (m, 3H), 7.15 (t, J = 7.47 
Hz, 1H), 4.26-4.13 (d, 1H), 3.02-2.87 (m, 
5H), 2.17 (m, 1H), 1.70 (m, 1H), 1.53-1.43 
(m, 1H), 1.10 (d, J = 6.90 Hz, 1H), 1.04 (t, J 
= 7.43 Hz, 2H), 0.95 (t, J = 7.39 Hz, 1H), 0.81 
(d, J = 6.81 Hz, 2H); 13C-NMR (400 MHz, 
CDCl3) δppm : 180.1, 161.1, 133.8, 128.2, 
127.7, 126.1, 125.2, 117.5, 71.9, 37.2, 26.6, 
25.9, 24.5, 13.9, 11.9; LRMS : (ES+) m/z = 
243.3 (Fragmented ion). 
(S)-3-methyl-3,4,6,7-tetrahydro-1H-
benzo[e][1,4]diazonine-2,5-dione (6e) 
Molecular Formula : C12H14N2O2; Rf: 0.2 
at 3 : 7 ethyl acetate/hexanes; Yield : 40 %; 
1H-NMR (400 MHz, CDCl3) δppm : 8.23 (d, 
J = 8.13 Hz, 1H), 7.39-7.30 (m, 2H), 7.20 (d, 
J = 7.31 Hz, 1H), 7.15 (t, J = 7.46 Hz, 1H), 
4.17 (m, 1H) , 2.95 (m, J = 7.47 Hz, 2H), 
2.90-2.85 (m, 2H),1.34(d, 3H); 13C-NMR 
(100 MHz, CDCl3) δppm : 178.5,161.2, 
134.7, 128.3, 127.8, 125.2, 123.8, 115.5, 72.6, 
30.7, 25.1, 18.8; LRMS : (ES+) m/z = 200.5 
(Fragmented ion). 
3,4,6,7-tetrahydro-1H-benzo[e][1,4]diazo-
nine-2,5-dione (6f) 
Molecular Formula : C11H12N2O2; Rf: 
0.35 at 3 : 7 ethyl acetate/hexanes; Yield : 
54 %; 1H-NMR (400 MHz, CDCl3) δppm : 
8.20 (d, J = 8.12 Hz, 1H), 7.38-7.31 (m, 2H), 
7.25 (d, J = 7.31 Hz, 1H), 7.14 (t, J = 7.55 
Hz, 1H), 4.15 (d, 2H) , 2.93 (m, J = 7.47 Hz, 
2H), 2.91-2.85 (m, 2H); 13C-NMR (100 MHz, 
CDCl3) δppm : 180.5,165.2, 136.8, 129.1, 
127.8, 124.7, 122.8, 112.5, 74.6, 38.7, 25.7; 
LRMS : (ES+) m/z = 185.7 (Fragmented ion). 
 
Antibacterial activity 
The title compounds were subjected for 
antibacterial activity, where Zone of inhibi-
tion (Pandey et al., 2010; Kirby and Bauer, 
1996) and Minimum inhibitory concentration 
(Sarker et al., 2007; Gibbons et al., 2002; Pra-
chayasittikul et al., 2010) test were conducted 
against test organism Bacillus subtilis which 
is a gram positive bacteria, by using Cup Plate 
Method and Microtitre Plate Method respec-
tively.  
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Determination of Zone of Inhibition - Cup 
Plate Method 
Cultures were sub-cultured on Nutrient 
Agar (NA) and Sabouraud Dextrose Agar 
(SDA) plates and further stored in slants as 
stock cultures. For the experiment, stock cul-
tures were prepared by inoculating each cul-
ture from slants to flask in sterile Nutrient 
Broth (NB) and incubated at 37 ºC for 24 h 
(Bacteria). The stock cultures were adjusted 
to 0.3 OD (Bacteria) at 650 nm by using spec-
trophotometer and used for assay. Sterile NA 
plates where prepared at 0.1 ml of inoculums 
from standardized culture of test organism 
and were spread evenly. A sterile borer was 
used to prepare wells with diameter 10 mm 
and 100 µl (in order to get the concentration 
of 1000, 500, 250 µg/well) of the test mate-
rial, standard antibiotic. A standard antibiotic, 
i.e., ciprofloxacin was tested against bacteria 
and was added in each well separately. At 
4 ºC the plates were kept for 1 h to carry out 
the diffusion of test solution into the medium, 
so that the plates were incubated at a temper-
ature best for the growth of test organism for 
a period of time enough for the growth of at 
least 10 to 15 generations. The zone of inhibi-
tion of microbial growth around the well was 
measured in mm. 
 
Determination of Minimum Inhibitory Con-
centration (MIC) - Microtitre Plate Method 
A sterile 96 well plate, prepared under 
aseptic conditions, was labelled. Into the first 
row of the plate a quantity of 100 µL of test 
material in DMSO (generally a stock concen-
tration of 0.2 mg/ml for purified material and 
2 mg/mL for crude extracts) was pipetted. 
50 µL of sterile broth was added to all other 
wells. Sterile dilutions were performed using 
multichannel pipette. Discard the tips after 
use, so that each well had 50 µL of the test 
compound in consecutively descending con-
centrations. Resazurin indicator solution was 
added to each well of 10 µL. A 30 µL of ster-
ile broth was added using a pipette. Lastly, 
microbial suspension of 10 µL was added to 
each well. By using cling film each plate was 
wrapped loosely to protect the culture from 
dehydration. Each plate has a set of positive, 
negative and standard solution. The prepared 
plates were placed in an incubator at temper-
ature 37 ºC for 18-24 h. The change in colour 
was then observed visually. The colour 
changes from purple to pink or colourless is 
taken as positive. The lowest concentration at 
which change in colour occurred was consid-
ered as MIC value. 
 
Molecular docking 
Docking studies were carried on windows 
2002 with MOE 2008.10 version according to 
reported method (Ravula et al., 2016a, b). 
From the protein data bank (PDB code: 
1G27), peptide deformylase enzyme was 
taken and visualized the receptor by using se-
quence option and deleted further co-factors. 
The ligand structures were written by using a 
builder module and the partial charges were 
adjusted and subsequently according to the 
standard geometry, 3D protonation and hy-
drogen addition was performed. At cut off 12 
using force field MMFF94x at 0.01KJ mole 
gradient the ligand’s energy minimized. By 
using the option simulation docking was per-
formed and was followed by using sequence 
option dock on selected active site amino ac-
ids were performed and eventually docked us-
ing setting options such as alpha triangle, re-
ceptor and solvent, affinity dG, selected resi-
dues, force field refinement and best 30 pose. 
After achieving docking results, best pose 
was retained out of the 30 best posed results 
for each chemical structure. The resultant best 
pose scores wereused for further examinina-
tion of docking and interaction. 
 
RESULTS AND DISCUSSION 
Synthesis started from the commercially 
available o-Nitrobenzaldehyde, it is subjected 
to Horner-Wittig reaction followed by ester 
hydrolysis obtained (E)-3-(2-nitrophenyl)-
acrylic acid (2). This was coupled with vari-
ous amino acid esters with the help of 1-hy-
droxy-1H-benzotriazole and di-isopropyl car-
bodiimide coupling reagents obtained (3a-f) 
in a good yield. This coupled product sub-
jected to hydrogenation on Pd/C which results 
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in one step nitro group and double bond re-
duction. The resulted ester (4a-f) again hydro-
lysed with Lithium hydroxide condition ob-
tained acid intermediate (5a-f). Finally ring 
closed with help of 1-Ethyl-3(3-dimethyla-
minopropyl) carbodiimide hydrochloride 
coupling reagent obtained a medium size ring 
(6a-f) on benzene (Figure 3). The final syn-
thesized molecules were purified by column 
chromatography and were analyzed by physi-
cal and analytical methods. 
 
Biological evaluation 
The newly synthesized compounds 6a-f 
were evaluated for their antibacterial activity 
(zone of inhibition and Minimum Inhibitory 
Concentration) against Bacillus subtilis, a 
gram positive organism. The screening data 
have been shown in Table 1, indicated that the 
compound 6d showed significant antibacte-
rial activity. Remaining compounds were 
found to possess moderate activity. Ciprof-
loxacin was used as standard, for both the test, 
its Minimum Inhibitory Concentration value 
is >7.8 µg/ml, whereas the title molecules are 
observed with value is 125 µg/ml shown in 
Figure 4 and 5. 
 
 
 
 
 
Figure 3: Synthesis of (S)-3-alkyl -3,4,6,7-tetrahydro-1H-benzo[e] [1,4]diazonine-2, 5-dione analogues 
(6a-f) 
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Figure 4: Zone of inhibition assay against B. subtilis by cup plate method 
 
 
 
Figure 5: Minimum Inhibitory Concentration activity of test samples against B. subtilis at different con-
centrations 
 
  
H 
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Table 1: Zone of inhibition and MIC value of final cyclized molecules 
S. No Sample Code Sample Name 
Zone of inhibition in 
mm (B.subtilis) 
MIC value 
1000 
µg/ml 
500 
µg/ml 
250 
µg/ml 
1 6a RR1292 15.6 13.3 10.0 125 µg/ml 
2 6b RR1293 15.0 14.0 13.0 125 µg/ml 
3 6c RR1294 10.0 12.0 12.0 125 µg/ml 
4 6d RR1295 18.6 17.6 15.6 125 µg/ml 
5 6e RR1296 13.0 14.0 12.0 125 µg/ml 
6 6f RR1297 12.0 11.0 13.0 125 µg/ml 
7 Standard 
(Ciprofloxacin) 
Std (1 mg/ml) 61.6 >7.8 µg/ml 
 
 
 
Molecular docking 
Molecular docking study was carried for 
further study of action of final compounds 
with peptide deformylase enzyme and eluci-
dated the observed biological results. Com-
paring of all final molecules, the docking re-
sults of compound 6d showed better interac-
tions of one hydrogen bond interaction i.e., 
oxygen of C=O and Arg 97; d=2.47Aº. Ben-
zene ring showed stacking interaction with 
Arg 97. Moreover molecule was surrounded 
by Glu 42, Cys90, Gly89 and Glu 87. This 
overall supports the results obtained for anti-
bacterial activity (Figure 6). 
 
 
Figure 6(A): Two-dimentional representation of 
the interaction mode of 6d with peptide deformyl-
ase enzyme. 
 
Figure 6(B): Three-dimentional structural model 
of compound 6d (purple) into peptide deformylase 
enzyme. 
 
 
CONCLUSION  
The novel analogues of lactam containing 
medium size ring molecules were synthesized 
and screened for antibacterial activity. Of all 
final compounds, compound 6d showed good 
bacterial inhibition and other compounds 
showed moderate inhibition. This was sup-
ported by molecular docking studies. With 
further molecular modification and QSAR of 
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these compounds, several other promising bi-
oactive molecules can be developed in future. 
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